Instituto Do Cancer Do Estado De São Paulo
Clinical trials sponsored by Instituto Do Cancer Do Estado De São Paulo, explained in plain language.
-
Promising combo for Hard-to-Treat prostate cancer enters first human tests
Disease control Not yet recruitingThis early-phase study tests a combination of chemotherapy (docetaxel) and a targeted radioactive drug (177Lu-PSMA) in 18 men with advanced prostate cancer that has stopped responding to hormone therapy. The main goal is to find the safest dose of the chemotherapy when given with…
Phase: PHASE1 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 26, 2026 12:10 UTC
-
New study aims to catch cervical cancer recurrence earlier with HPV testing
Knowledge-focused Not yet recruitingThis study will follow 100 people treated for advanced cervical cancer to see if checking for HPV and other biological markers can better predict if the cancer will come back. Current follow-up methods like Pap smears and scans are not always accurate after radiation. By finding …
Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Knowledge-focused
Last updated May 26, 2026 12:05 UTC